Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6104054, 14 pages
https://doi.org/10.1155/2017/6104054
Review Article

IL-10: A Multifunctional Cytokine in Viral Infections

Centro de Investigación en Sanidad Animal (CISA), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Valdeolmos, Madrid, Spain

Correspondence should be addressed to Noemí Sevilla; se.aini@allives

Received 14 November 2016; Revised 13 January 2017; Accepted 1 February 2017; Published 20 February 2017

Academic Editor: Abel Viejo-Borbolla

Copyright © 2017 José M. Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, “Regulation and functions of the IL-10 family of cytokines in inflammation and disease,” Annual Review of Immunology, vol. 29, pp. 71–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. G. Brooks, M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone, “Interleukin-10 determines viral clearance or persistence in vivo,” Nature Medicine, vol. 12, no. 11, pp. 1301–1309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Liu, S. H.-Y. Wei, A. S.-Y. Ho, R. De Waal Malefyt, and K. W. Moore, “Expression cloning and characterization of a human 11-10 receptor,” Journal of Immunology, vol. 152, no. 4, pp. 1821–1829, 1994. View at Google Scholar · View at Scopus
  4. K. W. Moore, R. De Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. J. K. Riley, K. Takeda, S. Akira, and R. D. Schreiber, “Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action,” Journal of Biological Chemistry, vol. 274, no. 23, pp. 16513–16521, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Meraz, J. M. White, K. C. F. Sheehan et al., “Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway,” Cell, vol. 84, no. 3, pp. 431–442, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S.-Y. Ho, S. H.-Y. Wei, A. L.-F. Mui, A. Miyajima, and K. W. Moore, “Functional regions of the mouse interleukin-10 receptor cytoplasmic domain,” Molecular and Cellular Biology, vol. 15, no. 9, pp. 5043–5053, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, “Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones,” Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081–20095, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. K. N. Couper, D. G. Blount, and E. M. Riley, “IL-10: the master regulator of immunity to infection,” Journal of Immunology, vol. 180, no. 9, pp. 5771–5777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Shen and S. Fillatreau, “Suppressive functions of B cells in infectious diseases,” International Immunology, vol. 27, no. 10, pp. 513–519, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Tilg, C. Van Montfrans, A. Van den Ende et al., “Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ,” Gut, vol. 50, no. 2, pp. 191–195, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. N. Lauw, D. Pajkrt, C. E. Hack, M. Kurimoto, S. J. H. Van Deventer, and T. Van der Poll, “Proinflammatory effects of IL-10 during human endotoxemia,” Journal of Immunology, vol. 165, no. 5, pp. 2783–2789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Cua, B. Hutchins, D. M. LaFace, S. A. Stohlman, and R. L. Coffman, “Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis,” Journal of Immunology, vol. 166, no. 1, pp. 602–608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Bettelli, M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo, “IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice,” Journal of Immunology, vol. 161, no. 7, pp. 3299–3306, 1998. View at Google Scholar · View at Scopus
  15. F. J. Barrat, D. J. Cua, A. Boonstra et al., “In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines,” Journal of Experimental Medicine, vol. 195, no. 5, pp. 603–616, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. R. Leon, W. Kozak, and M. J. Kluger, “Role of IL-10 in inflammation—studies using cytokine knockout mice,” Annals of the New York Academy of Sciences, vol. 856, pp. 69–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. Sellon, S. Tonkonogy, M. Schultz et al., “Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice,” Infection and Immunity, vol. 66, no. 11, pp. 5224–5231, 1998. View at Google Scholar · View at Scopus
  18. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, and W. Müller, “Interleukin-10-deficient mice develop chronic enterocolitis,” Cell, vol. 75, no. 2, pp. 263–274, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Rakoff-Nahoum, L. Hao, and R. Medzhitov, “Role of toll-like receptors in spontaneous commensal-dependent colitis,” Immunity, vol. 25, no. 2, pp. 319–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Hoshi, D. Schenten, S. A. Nish et al., “MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice,” Nature Communications, vol. 3, article no. 1120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. H. Uhlig, J. Coombes, C. Mottet et al., “Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis,” Journal of Immunology, vol. 177, no. 9, pp. 5852–5860, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi et al., “Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces,” Immunity, vol. 28, no. 4, pp. 546–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Chaudhry, R. M. Samstein, P. Treuting et al., “Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation,” Immunity, vol. 34, no. 4, pp. 566–578, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Zigmond, B. Bernshtein, G. Friedlander et al., “Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis,” Immunity, vol. 40, no. 5, pp. 720–733, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Murai, O. Turovskaya, G. Kim et al., “Interleukin 10 acts on regulatory t cells to maintain expression of the transcription factor foxp3 and suppressive function in mice with colitis,” Nature Immunology, vol. 10, no. 11, pp. 1178–1184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Shouval, A. Biswas, J. A. Goettel et al., “Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function,” Immunity, vol. 40, no. 5, pp. 706–719, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. M. Beebe, D. J. Cua, and R. De Waal Malefyt, “The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS),” Cytokine and Growth Factor Reviews, vol. 13, no. 4-5, pp. 403–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Hata, N. Sakaguchi, H. Yoshitomi et al., “Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice,” Journal of Clinical Investigation, vol. 114, no. 4, pp. 582–588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Bai, J. Zhu, G. Zhang et al., “IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses,” Clinical Immunology and Immunopathology, vol. 83, no. 2, pp. 117–126, 1997. View at Publisher · View at Google Scholar
  30. S. Tartey and O. Takeuchi, “Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells,” International Reviews of Immunology, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  31. M. Ejrnaes, C. M. Filippi, M. M. Martinic et al., “Resolution of a chronic viral infection after interleukin-10 receptor blockade,” Journal of Experimental Medicine, vol. 203, no. 11, pp. 2461–2472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. S. M. Ng, A. Li, G. N. Pavlakis, K. Ozato, and T. Kino, “Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications,” PLOS ONE, vol. 8, no. 5, Article ID e63587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Samarasinghe, P. Tailor, T. Tamura, T. Kaisho, S. Akira, and K. Ozato, “Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling,” Journal of Interferon and Cytokine Research, vol. 26, no. 12, pp. 893–900, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Javad Aman, T. Tretter, I. Eisenbeis et al., “Interferon-α stimulates production of interleukin-10 in activated CD4+ T cells and monocytes,” Blood, vol. 87, no. 11, pp. 4731–4736, 1996. View at Google Scholar · View at Scopus
  35. E. Y. Chang, B. Guo, S. E. Doyle, and G. Cheng, “Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production,” Journal of Immunology, vol. 178, no. 11, pp. 6705–6709, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. Pattison, K. F. MacKenzie, and J. S. C. Arthur, “Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback,” Journal of Immunology, vol. 189, no. 6, pp. 2784–2792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Boonstra, R. Rajsbaum, M. Holman et al., “Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals,” Journal of Immunology, vol. 177, no. 11, pp. 7551–7558, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Howes, C. Taubert, S. Blankley et al., “Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages,” The Journal of Immunology, vol. 197, no. 7, pp. 2838–2853, 2016. View at Publisher · View at Google Scholar
  39. K. F. MacKenzie, K. Clark, S. Naqvi et al., “PGE2 induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway,” Journal of Immunology, vol. 190, no. 2, pp. 565–577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. D. Edwards, S. P. Manickasingham, R. Spörri et al., “Microbial recognition via toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering,” Journal of Immunology, vol. 169, no. 7, pp. 3652–3660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Hu, P. K. Paik, J. Chen et al., “IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins,” Immunity, vol. 24, no. 5, pp. 563–574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. G. Brown, A. O. Dokun, J. W. Heusel et al., “Vital involvement of a natural killer cell activation receptor in resistance to viral infection,” Science, vol. 292, no. 5518, pp. 934–937, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. H. E. Farrell, K. Bruce, C. Lawler et al., “Type 1 interferons and NK cells limit murine cytomegalovirus escape from the lymph node subcapsular sinus,” PLOS Pathogens, vol. 12, no. 12, Article ID e1006069, 2016. View at Publisher · View at Google Scholar
  44. C. Lawler, C. S. Tan, J. P. Simas, P. G. Stevenson, and R. M. Longnecker, “Type I interferons and NK cells restrict gammaherpesvirus lymph node infection,” Journal of Virology, vol. 90, no. 20, pp. 9046–9057, 2016. View at Publisher · View at Google Scholar
  45. O. Chijioke, A. Müller, R. Feederle et al., “Human natural killer cells prevent infectious mononucleosis features by targeting lytic epstein-barr virus infection,” Cell Reports, vol. 5, no. 6, pp. 1489–1498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Qian, X. Jiang, H. An et al., “TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation,” Blood, vol. 108, no. 7, pp. 2307–2315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Mocellin, M. Panelli, E. Wang et al., “IL-10 stimulatory effects on human NK cells explored by gene profile analysis,” Genes and Immunity, vol. 5, no. 8, pp. 621–630, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Cai, R. A. Kastelein, and C. A. Hunter, “IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18,” European Journal of Immunology, vol. 29, no. 9, pp. 2658–2665, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. W. E. Carson, M. J. Lindemann, R. Baiocchi et al., “The functional characterization of interleukin-10 receptor expression on human natural killer cells,” Blood, vol. 85, no. 12, pp. 3577–3585, 1995. View at Google Scholar · View at Scopus
  50. Y. Shibata, L. A. Foster, M. Kurimoto et al., “Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ,” Journal of Immunology, vol. 161, no. 8, pp. 4283–4288, 1998. View at Google Scholar · View at Scopus
  51. B.-C. Chiu, V. R. Stolberg, and S. W. Chensue, “Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-γ axis in lung-challenged aged mice,” Journal of Immunology, vol. 181, no. 5, pp. 3156–3166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. Scott, J. J. Hoth, M. Turina, D. R. Woods, and W. G. Cheadle, “Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection,” Cytokine, vol. 33, no. 2, pp. 79–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Stacey, M. Marsden, E. C. Y. Wang, G. W. G. Wilkinson, and I. R. Humphreys, “IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection,” Journal of Immunology, vol. 187, no. 6, pp. 2944–2952, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. J. H. Bream, R. E. Curiel, C.-R. Yu et al., “IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells,” Blood, vol. 102, no. 1, pp. 207–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Bodas, N. Jain, A. Awasthi et al., “Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy,” Journal of Immunology, vol. 177, no. 7, pp. 4636–4643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. M. J. Loza and B. Perussia, “The IL-12 signature: NK cell terminal CD56+high stage and effector functions,” Journal of Immunology, vol. 172, no. 1, pp. 88–96, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. L. R. Grant, Z.-J. Yao, C. M. Hedrich et al., “Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells,” Genes and Immunity, vol. 9, no. 4, pp. 316–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. P. J. Gaddi, M. J. Crane, M. Kamanaka, R. A. Flavell, G. S. Yap, and T. P. Salazar-Mather, “IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection,” PLoS ONE, vol. 7, no. 8, Article ID e42850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S.-H. Lee, K.-S. Kim, N. Fodil-Cornu, S. M. Vidal, and C. A. Biron, “Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection,” Journal of Experimental Medicine, vol. 206, no. 10, pp. 2235–2251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Maroof, L. Beattie, S. Zubairi, M. Svensson, S. Stager, and P. M. Kaye, “Posttranscriptional regulation of Il10 gene expression allows natural killer cells to express immunoregulatory function,” Immunity, vol. 29, no. 2, pp. 295–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Maldonado-López and M. Moser, “Dendritic cell subsets and the regulation of Th1/Th2 responses,” Seminars in Immunology, vol. 13, no. 5, pp. 275–282, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Y. Ma and E. A. Clark, “The role of CD40 and CD154/CD40L in dendritic cells,” Seminars in Immunology, vol. 21, no. 5, pp. 265–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. S. S. Puntambekar, C. C. Bergmann, C. Savarin et al., “Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis,” Journal of Virology, vol. 85, no. 13, pp. 6702–6713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Saraiva and A. O'Garra, “The regulation of IL-10 production by immune cells,” Nature Reviews Immunology, vol. 10, no. 3, pp. 170–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. C. L. Maynard and C. T. Weaver, “Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation,” Immunological Reviews, vol. 226, no. 1, pp. 219–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. S. S. Cush, G. V. Reynoso, O. Kamenyeva, J. R. Bennink, J. W. Yewdell, and H. D. Hickman, “Locally produced IL-10 limits cutaneous vaccinia virus spread,” PLOS Pathogens, vol. 12, no. 3, Article ID e1005493, 2016. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Jiang, S. Yao, S. Huang, J. Wright, T. J. Braciale, and J. Sun, “Type I IFN signaling facilitates the development of IL-10-producing effector CD8+ T cells during murine influenza virus infection,” European Journal of Immunology, vol. 46, no. 12, pp. 2778–2788, 2016. View at Publisher · View at Google Scholar
  68. J. Sun, R. Madan, C. L. Karp, and T. J. Braciale, “Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10,” Nature Medicine, vol. 15, no. 3, pp. 277–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Trandem, J. Zhao, E. Fleming, and S. Perlman, “Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis,” Journal of Immunology, vol. 186, no. 6, pp. 3642–3652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Loebbermann, C. Schnoeller, H. Thornton et al., “IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice,” PLoS ONE, vol. 7, no. 2, Article ID e32371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. E. M. Palmer, B. C. Holbrook, S. Arimilli, G. D. Parks, and M. A. Alexander-Miller, “IFNγ-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment,” Virology, vol. 404, no. 2, pp. 225–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. I. A. Parish, H. D. Marshall, M. M. Staron et al., “Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1,” Journal of Clinical Investigation, vol. 124, no. 8, pp. 3455–3468, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. A. O'Garra and P. Vieira, “TH1 cells control themselves by producing interleukin-10,” Nature Reviews Immunology, vol. 7, no. 6, pp. 425–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. A. P. F. Do Rosário, T. Lamb, P. Spence et al., “IL-27 promotes IL-10 production by effector Th1 CD4+T cells: a critical mechanism for protection from severe immunopathology during malaria infection,” Journal of Immunology, vol. 188, no. 3, pp. 1178–1190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Jankovic, M. C. Kullberg, C. G. Feng et al., “Conventional T-bet+Foxp3 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection,” Journal of Experimental Medicine, vol. 204, no. 2, pp. 273–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Richter, G. Perriard, R. Behrendt et al., “Macrophage and T cell produced IL-10 promotes viral chronicity,” PLoS Pathogens, vol. 9, no. 11, Article ID e1003735, 2013. View at Publisher · View at Google Scholar
  77. I. R. Humphreys, C. De Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware, “Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands,” Journal of Experimental Medicine, vol. 204, no. 5, pp. 1217–1225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Redpath, A. Angulo, N. R. J. Gascoigne, and P. Ghazal, “Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10,” Journal of Immunology, vol. 162, no. 11, pp. 6701–6707, 1999. View at Google Scholar · View at Scopus
  79. M. Clement, M. Marsden, M. A. Stacey et al., “Cytomegalovirus-specific IL-10-producing CD4+ T cells are governed by type-I IFN-induced IL-27 and promote virus persistence,” PLOS Pathogens, vol. 12, no. 12, p. e1006050, 2016. View at Publisher · View at Google Scholar
  80. S. Rutz and W. Ouyang, “Regulation of interleukin-10 expression,” in Regulation of Cytokine Gene Expression in Immunity and Diseases, vol. 941 of Advances in Experimental Medicine and Biology, pp. 89–116, Springer, Dordrecht, Netherlands, 2016. View at Publisher · View at Google Scholar
  81. M. Kubo and Y. Motomura, “Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells,” Frontiers in Immunology, vol. 3, article 275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Awasthi, Y. Carrier, J. P. S. Peron et al., “A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells,” Nature Immunology, vol. 8, no. 12, pp. 1380–1389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Batten, N. M. Kljavin, J. Li, M. J. Walter, F. J. De Sauvage, and N. Ghilardi, “Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells,” Journal of Immunology, vol. 180, no. 5, pp. 2752–2756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. D. C. Fitzgerald, G. X. Zhang, M. El-Behi et al., “Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells,” Nature Immunology, vol. 8, no. 12, pp. 1372–1379, 2007. View at Google Scholar
  85. G. Murugaiyan, A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner, “IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells,” Journal of Immunology, vol. 183, no. 4, pp. 2435–2443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Zhang, S. Yuan, G. Cheng, and B. Guo, “Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation,” PLoS ONE, vol. 6, no. 12, Article ID e28432, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. M. K. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. De Waal Malefyt, and M.-G. Roncarolo, “IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells,” Journal of Immunology, vol. 166, no. 9, pp. 5530–5539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. J. S. Stumhofer, J. S. Silver, A. Laurence et al., “Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10,” Nature Immunology, vol. 8, no. 12, pp. 1363–1371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. C. L. Maynard, L. E. Harrington, K. M. Janowski et al., “Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3 precursor cells in the absence of interleukin 10,” Nature Immunology, vol. 8, no. 9, pp. 931–941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. D. G. Brooks, L. Teyton, M. B. A. Oldstone, and D. B. McGavern, “Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection,” Journal of Virology, vol. 79, no. 16, pp. 10514–10527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Gallimore, A. Glithero, A. Godkin et al., “Induction and exhaustion of lymphocytic choriomeningitis virus–specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I–peptide complexes,” Journal of Experimental Medicine, vol. 187, no. 9, pp. 1383–1393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Sun, H. Dodd, E. K. Moser, R. Sharma, and T. J. Braciale, “CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs,” Nature Immunology, vol. 12, no. 4, pp. 327–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. T. De Smedt, M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser, “Effect of interleukin-10 on dendritic cell maturation and function,” European Journal of Immunology, vol. 27, no. 5, pp. 1229–1235, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Capsoni, F. Minonzio, A. M. Ongari, V. Carbonelli, A. Galli, and C. Zanussi, “IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ,” Journal of Leukocyte Biology, vol. 58, no. 3, pp. 351–358, 1995. View at Google Scholar · View at Scopus
  95. D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra, “IL-10 inhibits cytokine production by activated macrophages,” Journal of Immunology, vol. 147, no. 11, pp. 3815–3822, 1991. View at Google Scholar · View at Scopus
  96. N. Makita, Y. Hizukuri, K. Yamashiro, M. Murakawa, and Y. Hayashi, “IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration,” International Immunology, vol. 27, no. 3, pp. 131–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Corinti, C. Albanesi, A. La Sala, S. Pastore, and G. Girolomoni, “Regulatory activity of autocrine IL-10 on dendritic cell functions,” Journal of Immunology, vol. 166, no. 7, pp. 4312–4318, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Bhattacharyya, P. Sen, M. Wallet, B. Long, A. S. Baldwin Jr., and R. Tisch, “Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IκB kinase activity,” Blood, vol. 104, no. 4, pp. 1100–1109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. F. O. Martinez and S. Gordon, “The M1 and M2 paradigm of macrophage activation: time for reassessment,” F1000Prime Reports, vol. 6, article 13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. A. D'Andrea, M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri, “Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells,” Journal of Experimental Medicine, vol. 178, no. 3, pp. 1041–1048, 1993. View at Publisher · View at Google Scholar · View at Scopus
  101. X. Ma, W. Yan, H. Zheng et al., “Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells,” F1000Research, vol. 4, 2015. View at Publisher · View at Google Scholar
  102. L. Gabryšová, K. S. Nicolson, H. B. Streeter et al., “Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells,” Journal of Experimental Medicine, vol. 206, no. 8, pp. 1755–1767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. C. Demangel, P. Bertolino, and W. J. Britton, “Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production,” European Journal of Immunology, vol. 32, no. 4, pp. 994–1002, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Tian, S. B. Mollo, L. E. Harrington, and A. J. Zajac, “IL-10 regulates memory T cell development and the balance between Th1 and follicular Th cell responses during an acute viral infection,” The Journal of Immunology, vol. 197, no. 4, pp. 1308–1321, 2016. View at Publisher · View at Google Scholar · View at Scopus
  105. X. S. Liu, Y. Xu, L. Hardy et al., “IL-10 mediates suppression of the CD8 T cell IFN-γ response to a novel viral epitope in a primed host,” The Journal of Immunology, vol. 171, no. 9, pp. 4765–4772, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Snell, I. Osokine, D. Yamada, J. De la Fuente, H. Elsaesser, and D. Brooks, “Overcoming CD4 Th1 cell fate restrictions to sustain antiviral CD8 T cells and control persistent virus infection,” Cell Reports, vol. 16, no. 12, pp. 3286–3296, 2016. View at Publisher · View at Google Scholar
  107. D. G. Brooks, K. B. Walsh, H. Elsaesser, and M. B. A. Oldstone, “IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3018–3023, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Richter and A. Oxenius, “Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement,” European Journal of Immunology, vol. 43, no. 9, pp. 2349–2360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. K. A. Kulcsar, V. K. Baxter, I. P. Greene, and D. E. Griffin, “Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 45, pp. 16053–16058, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. K. E. Foulds, M. J. Rotte, and R. A. Seder, “IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection,” The Journal of Immunology, vol. 177, no. 4, pp. 2565–2574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. W. Cui, Y. Liu, J. S. Weinstein, J. Craft, and S. M. Kaech, “An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells,” Immunity, vol. 35, no. 5, pp. 792–805, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. B. J. Laidlaw, W. Cui, R. A. Amezquita et al., “Production of IL-10 by CD4+ regulatory T cells during the resolution of infection promotes the maturation of memory CD8+ T cells,” Nature Immunology, vol. 16, no. 8, pp. 871–879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. T. Dörner and A. Radbruch, “Antibodies and B cell memory in viral immunity,” Immunity, vol. 27, no. 3, pp. 384–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. N. L. Letvin, “Correlates of immune protection and the development of a human immunodeficiency virus vaccine,” Immunity, vol. 27, no. 3, pp. 366–369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. R. M. Zinkernagel and H. Hengartner, “Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called ‘immunological memory’,” Immunological Reviews, vol. 211, pp. 310–319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Melzi, M. Caporale, M. Rocchi et al., “Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 41, pp. E6238–E6247, 2016. View at Publisher · View at Google Scholar
  117. D. D. Richman, T. Wrin, S. J. Little, and C. J. Petropoulos, “Rapid evolution of the neutralizing antibody response to HIV type 1 infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4144–4149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  118. X. Wei, J. M. Decker, S. Wang et al., “Antibody neutralization and escape by HIV-1,” Nature, vol. 422, no. 6929, pp. 307–312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  119. K. Itoh and S. Hirohata, “The role of IL-10 in human B cell activation, proliferation, and differentiation,” Journal of Immunology, vol. 154, no. 9, pp. 4341–4350, 1995. View at Google Scholar · View at Scopus
  120. H. Gary-Gouy, J. Harriague, G. Bismuth, C. Platzer, C. Schmitt, and A. H. Dalloul, “Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production,” Blood, vol. 100, no. 13, pp. 4537–4543, 2002. View at Publisher · View at Google Scholar · View at Scopus
  121. N. Shparago, P. Zelazowski, L. Jin et al., “IL-10 selectively regulates murine Ig isotype switching,” International Immunology, vol. 8, no. 5, pp. 781–790, 1996. View at Publisher · View at Google Scholar · View at Scopus
  122. F. Malisan, F. Brière, J.-M. Bridon et al., “Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes,” Journal of Experimental Medicine, vol. 183, no. 3, pp. 937–947, 1996. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Agrawal and S. Gupta, “TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors,” Journal of Clinical Immunology, vol. 31, no. 1, pp. 89–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  124. V. Lampropoulou, K. Hoehlig, T. Roch et al., “TLR-activated B cells suppress T cell-mediated autoimmunity,” Journal of Immunology, vol. 180, no. 7, pp. 4763–4773, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Sayi, E. Kohler, I. M. Toller et al., “TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells,” Journal of Immunology, vol. 186, no. 2, pp. 878–890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  126. J. Skok, J. Poudrier, and D. Gray, “Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development,” Journal of Immunology, vol. 163, no. 8, pp. 4284–4291, 1999. View at Google Scholar · View at Scopus
  127. L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora, “IFN-α amplifies human naïve B cell TLR-9-mediated activation and Ig production,” Journal of Leukocyte Biology, vol. 86, no. 2, pp. 261–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. X. Zhang, E. Deriaud, X. Jiao, D. Braun, C. Leclerc, and R. Lo-Man, “Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells,” Journal of Experimental Medicine, vol. 204, no. 5, pp. 1107–1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan, “Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation,” Immunity, vol. 16, no. 2, pp. 219–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  130. K. Yanaba, J.-D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder, “A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses,” Immunity, vol. 28, no. 5, pp. 639–650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. K. M. Candando, J. M. Lykken, and T. F. Tedder, “B10 cell regulation of health and disease,” Immunological Reviews, vol. 259, no. 1, pp. 259–272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. J. M. Lykken, K. M. Candando, and T. F. Tedder, “Regulatory B10 cell development and function,” International Immunology, vol. 27, no. 10, pp. 471–477, 2015. View at Publisher · View at Google Scholar · View at Scopus
  133. N. Matsushita, S. A. Pilon-Thomas, L. M. Martin, and A. I. Riker, “Comparative methodologies of regulatory T cell depletion in a murine melanoma model,” Journal of Immunological Methods, vol. 333, no. 1-2, pp. 167–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Yoshizaki, T. Miyagaki, D. J. Dilillo et al., “Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions,” Nature, vol. 491, no. 7423, pp. 264–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Horikawa, E. T. Weimer, D. J. DiLillo et al., “Regulatory B Cell (B10 Cell) expansion during listeria infection governs innate and cellular immune responses in mice,” Journal of Immunology, vol. 190, no. 3, pp. 1158–1168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. P. Neves, V. Lampropoulou, E. Calderon-Gomez et al., “Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during salmonella typhimurium infection,” Immunity, vol. 33, no. 5, pp. 777–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Amu, S. P. Saunders, M. Kronenberg, N. E. Mangan, A. Atzberger, and P. G. Fallon, “Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model,” Journal of Allergy and Clinical Immunology, vol. 125, no. 5, pp. 1114–1124.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. Z. Cen, Y. Guo, Q. Kong, Q. Zhou, and W. Wu, “IL-10-producing B cells involved in the pathogenesis of Coxsackie virus B3-induced acute viral myocarditis,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 1, pp. 830–835, 2015. View at Google Scholar · View at Scopus
  139. M. Jones, K. Ladell, K. K. Wynn et al., “IL-10 restricts memory T cell inflation during cytomegalovirus infection,” Journal of Immunology, vol. 185, no. 6, pp. 3583–3592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  140. R. Madan, F. Demircik, S. Surianarayanan et al., “Nonredundant roles for B cell-derived IL-10 in immune counter-regulation,” Journal of Immunology, vol. 183, no. 4, pp. 2312–2320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. M. B. Mutnal, S. Hu, S. J. Schachtele, and J. R. Lokensgard, “Infiltrating regulatory B cells control neuroinflammation following viral brain infection,” Journal of Immunology, vol. 193, no. 12, pp. 6070–6080, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. J. Liu, W. Zhan, C. J. Kim et al., “IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses,” PLoS ONE, vol. 9, no. 2, Article ID e89236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. A. Das, G. Ellis, C. Pallant et al., “IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection,” The Journal of Immunology, vol. 189, no. 8, pp. 3925–3935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. D. D. Naicker, L. Werner, E. Kormuth et al., “Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis,” The Journal of Infectious Diseases, vol. 200, no. 3, pp. 448–452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  145. D. Verhoeven and S. Perry, “Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults,” Immunology and Cell Biology, 2016. View at Publisher · View at Google Scholar
  146. M. M. N. Tun, K. Aoki, M. Senba et al., “Protective role of TNF-α, IL-10 and IL-2 in mice infected with the Oshima strain of Tick-borne encephalitis virus,” Scientific Reports, vol. 4, article no. 5344, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. V. Saxena, A. Mathur, N. Krishnani, and T. N. Dhole, “An insufficient anti-inflammatory cytokine response in mouse brain is associated with increased tissue pathology and viral load during Japanese encephalitis virus infection,” Archives of Virology, vol. 153, no. 2, pp. 283–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  148. J. H. Kim, A. M. Patil, J. Y. Choi et al., “CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4+Foxp3+ T and IL-17+CD4+ Th17 cells,” Journal of Neuroinflammation, vol. 13, no. 1, article 223, 2016. View at Publisher · View at Google Scholar
  149. M. T. Lin, D. R. Hinton, B. Parra, S. A. Stohlman, and R. C. Van Der Veen, “The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis,” Virology, vol. 245, no. 2, pp. 270–280, 1998. View at Publisher · View at Google Scholar · View at Scopus
  150. E. J. Wherry, “T cell exhaustion,” Nature Immunology, vol. 12, no. 6, pp. 492–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. E. J. Wherry, J. N. Blattman, K. Murali-Krishna, R. Van Der Most, and R. Ahmed, “Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment,” Journal of Virology, vol. 77, no. 8, pp. 4911–4927, 2003. View at Publisher · View at Google Scholar · View at Scopus
  152. D. L. Barber, E. J. Wherry, D. Masopust et al., “Restoring function in exhausted CD8 T cells during chronic viral infection,” Nature, vol. 439, no. 7077, pp. 682–687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  153. S. D. Blackburn, H. Shin, W. N. Haining et al., “Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection,” Nature Immunology, vol. 10, no. 1, pp. 29–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. R. Tinoco, V. Alcalde, Y. Yang, K. Sauer, and E. I. Zuniga, “Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo,” Immunity, vol. 31, no. 1, pp. 145–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. E. B. Wilson and D. G. Brooks, “The role of IL-10 in regulating immunity to persistent viral infections,” Current topics in microbiology and immunology, vol. 350, pp. 39–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. S. D. Blackburn and E. J. Wherry, “IL-10, T cell exhaustion and viral persistence,” Trends in Microbiology, vol. 15, no. 4, pp. 143–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  157. J. K. Flynn, G. J. Dore, M. Hellard et al., “Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users,” Journal of Viral Hepatitis, vol. 18, no. 8, pp. 549–561, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. A. De Maria, M. Fogli, S. Mazza et al., “Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients,” European Journal of Immunology, vol. 37, no. 2, pp. 445–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. E. A. Said, F. P. Dupuy, L. Trautmann et al., “Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection,” Nature Medicine, vol. 16, no. 4, pp. 452–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. M. A. Brockman, D. S. Kwon, D. P. Tighe et al., “IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells,” Blood, vol. 114, no. 2, pp. 346–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. N. Sevilla, S. Kunz, A. Holz et al., “Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells,” Journal of Experimental Medicine, vol. 192, no. 9, pp. 1249–1260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  162. N. Sevilla, D. B. McGavern, C. Teng, S. Kunz, and M. B. A. Oldstone, “Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion,” Journal of Clinical Investigation, vol. 113, no. 5, pp. 737–745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  163. M. B. A. Oldstone, “Biology and pathogenesis of lymphocytic choriomeningitis virus infection,” Current Topics in Microbiology and Immunology, vol. 263, pp. 83–117, 2002. View at Google Scholar · View at Scopus
  164. C. T. Ng and M. B. A. Oldstone, “Infected CD8α dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14116–14121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  165. K. Saito, M. Ait-Goughoulte, S. M. Truscott et al., “Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production,” Journal of Virology, vol. 82, no. 7, pp. 3320–3328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  166. C.-C. Liang, C.-H. Liu, Y.-L. Lin, C.-J. Liu, B.-L. Chiang, and J.-H. Kao, “Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy,” Journal of Medical Virology, vol. 83, no. 7, pp. 1212–1220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  167. G. Alter, D. Kavanagh, S. Rihn et al., “IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 1905–1913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. S. Buisson, A. Benlahrech, B. Gazzard, F. Gotch, P. Kelleher, and S. Patterson, “Monocyte-derived dendritic cells from HIV type 1-Infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10,” Journal of Infectious Diseases, vol. 199, no. 12, pp. 1862–1871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  169. F. Díaz-San Segundo, T. Rodríguez-Calvo, A. de Avila, and N. Sevilla, “Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10,” PLoS ONE, vol. 4, no. 5, Article ID e5659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  170. M. Ostrowski, M. Vermeulen, O. Zabal, J. R. Geffner, A. M. Sadir, and O. J. Lopez, “Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus,” Journal of Immunology, vol. 175, no. 6, pp. 3971–3979, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. N. Sánchez-Sánchez, L. Riol-Blanco, and J. L. Rodríguez-Fernández, “The multiple personalities of the chemokine receptor CCR7 in dendritic cells,” Journal of Immunology, vol. 176, no. 9, pp. 5153–5159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. S. Nylén, R. Maurya, L. Eidsmo, K. Das Manandhar, S. Sundar, and D. Sacks, “Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis,” Journal of Experimental Medicine, vol. 204, no. 4, pp. 805–817, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. T. H. Ng, G. J. Britton, E. V. Hill, J. Verhagen, B. R. Burton, and D. C. Wraith, “Regulation of adaptive immunity; the role of interleukin-10,” Frontiers in Immunology, vol. 4, article 129, 2013. View at Publisher · View at Google Scholar
  174. C. H. Maris, C. P. Chappell, and J. Jacob, “Interleukin-10 plays an early role in generating virus-specific T cell anergy,” BMC Immunology, vol. 8, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  175. M. F. Chevalier, C. Didier, G. Petitjean et al., “Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells,” Journal of Infectious Diseases, vol. 211, no. 5, pp. 769–779, 2015. View at Publisher · View at Google Scholar · View at Scopus
  176. H. Groux, A. O'Garra, M. Bigler et al., “A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis,” Nature, vol. 389, no. 6652, pp. 737–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  177. S. Gregori, D. Tomasoni, V. Pacciani et al., “Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway,” Blood, vol. 116, no. 6, pp. 935–944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  178. S. H. Speck and D. Ganem, “Viral latency and its regulation: lessons from the γ-herpesviruses,” Cell Host and Microbe, vol. 8, no. 1, pp. 100–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. A. Alcami, “Viral mimicry of cytokines, chemokines and their receptors,” Nature Reviews Immunology, vol. 3, no. 1, pp. 36–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. A. Alcami and U. H. Koszinowski, “Viral mechanisms of immune evasion,” Trends in Microbiology, vol. 8, no. 9, pp. 410–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  181. B. P. McSharry, S. Avdic, and B. Slobedman, “Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation,” Viruses, vol. 4, no. 11, pp. 2448–2470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  182. K. W. Moore, P. Vieira, D. F. Fiorentino, M. L. Trounstine, T. A. Khan, and T. R. Mosmann, “Homology of cytokine synthesis inhibitory factor (IL-10) to the epstein-barr virus gene BCRFI,” Science, vol. 248, no. 4960, pp. 1230–1234, 1990. View at Publisher · View at Google Scholar · View at Scopus
  183. G. Jayawardane, G. C. Russell, J. Thomson et al., “A captured viral interleukin 10 gene with cellular exon structure,” Journal of General Virology, vol. 89, no. 10, pp. 2447–2455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. E. A. R. Telford, M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison, “The DNA sequence of equine herpesvirus 2,” Journal of Molecular Biology, vol. 249, no. 3, pp. 520–528, 1995. View at Publisher · View at Google Scholar · View at Scopus
  185. B. Slobedman, P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth, “Virus-encoded homologs of cellular interleukin-10 and their control of host immune function,” Journal of Virology, vol. 83, no. 19, pp. 9618–9629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  186. M. B. Reeves, P. A. MacAry, P. J. Lehner, J. G. P. Sissons, and J. H. Sinclair, “Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 11, pp. 4140–4145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  187. S. V. Kotenko, S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka, “Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10),” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1695–1700, 2000. View at Publisher · View at Google Scholar · View at Scopus
  188. C. Jenkins, A. Abendroth, and B. Slobedman, “A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection,” Journal of Virology, vol. 78, no. 3, pp. 1440–1447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  189. J. V. Spencer, K. M. Lockridge, P. A. Barry et al., “Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10,” Journal of Virology, vol. 76, no. 3, pp. 1285–1292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  190. S. Avdic, B. P. McSharry, and B. Slobedman, “Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus,” Frontiers in Microbiology, vol. 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  191. S. Gordon, “Alternative activation of macrophages,” Nature Reviews Immunology, vol. 3, no. 1, pp. 23–35, 2003. View at Publisher · View at Google Scholar · View at Scopus
  192. S. Avdic, J. Z. Cao, B. P. McSharry et al., “Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated m2c phenotype to repress host immune responses,” Journal of Virology, vol. 87, no. 18, pp. 10273–10282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  193. S. Avdic, B. P. McSharry, M. Steain et al., “Human cytomegalovirus-encoded human interleukin-10 (IL-10) homolog amplifies its immunomodulatory potential by upregulating human IL-10 in monocytes,” Journal of Virology, vol. 90, no. 8, pp. 3819–3827, 2016. View at Publisher · View at Google Scholar · View at Scopus
  194. M. K. Eberhardt, A. Deshpande, J. Fike et al., “Exploitation of interleukin-10 (IL-10) signaling pathways: alternate roles of viral and cellular IL-10 in rhesus cytomegalovirus infection,” Journal of Virology, vol. 90, no. 21, pp. 9920–9930, 2016. View at Publisher · View at Google Scholar
  195. G. M. Mason, S. Jackson, G. Okecha et al., “Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4+ T cells,” PLoS Pathogens, vol. 9, no. 10, Article ID e1003635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  196. C. Jenkins, W. Garcia, M. J. Godwin et al., “Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection,” Journal of Virology, vol. 82, no. 7, pp. 3736–3750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  197. J. V. Spencer, J. Cadaoas, P. R. Castillo, V. Saini, and B. Slobedman, “Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10,” Virology, vol. 374, no. 1, pp. 164–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  198. L. S. Young and A. B. Rickinson, “Epstein-Barr virus: 40 years on,” Nature Reviews Cancer, vol. 4, no. 10, pp. 757–768, 2004. View at Publisher · View at Google Scholar · View at Scopus
  199. S. Jochum, A. Moosmann, S. Lang, W. Hammerschmidt, and R. Zeidler, “The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination,” PLOS Pathogens, vol. 8, no. 5, Article ID e1002704, 2012. View at Publisher · View at Google Scholar · View at Scopus
  200. S. I. Yoon, B. C. Jones, N. J. Logsdon, and M. R. Walter, “Same structure, different function: crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10r1 chain,” Structure, vol. 13, no. 4, pp. 551–564, 2005. View at Publisher · View at Google Scholar · View at Scopus
  201. S. I. Yoon, B. C. Jones, N. J. Logsdon, B. D. Harris, S. Kuruganti, and M. R. Walter, “Epstein-barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties,” Journal of Biological Chemistry, vol. 287, no. 32, pp. 26586–26595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  202. P. Vieira, R. De Waal-Malefyt, M.-N. Dang et al., “Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 4, pp. 1172–1176, 1991. View at Publisher · View at Google Scholar · View at Scopus
  203. Y. Ding, L. Qin, S. V. Kotenko, S. Pestka, and J. S. Bromberg, “A single amino acid determines the immunostimulatory activity of interleukin 10,” Journal of Experimental Medicine, vol. 191, no. 2, pp. 213–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  204. G. J. Lindquester, K. A. Greer, J. P. Stewart, and J. T. Sample, “Epstein-Barr virus IL-10 gene expression by a recombinant murine gammaherpesvirus in vivo enhances acute pathogenicity but does not affect latency or reactivation,” Herpesviridae, vol. 5, article 1, 2014. View at Publisher · View at Google Scholar